Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 56 (LRRC56) is a conserved cytoplasmic protein found in species with motile cilia that rely on intraflagellar transport (IFT) for axonemal assembly. In humans, LRRC56 is essential for the assembly of outer dynein arms at the distal segment of the axoneme, a core structural feature of motile cilia and flagella. LRRC56 interacts with IFT proteins, notably IFT88, and functions as a cargo adaptor to facilitate dynein transport to cilia during formation. Deleterious mutations in LRRC56 lead to defects in ciliary motility without conspicuous ultrastructural abnormalities, resulting in primary ciliary dyskinesia, reduced mucociliary clearance, recurrent respiratory infections, fertility-related disorders, and laterality defects (abnormal organ positioning). The protein is predominantly expressed in ciliated tissues including testis, pituitary gland, and respiratory epithelium. No drugs are known to interact with LRRC56, and it is not a classical receptor or enzyme but rather a structural and assembly factor critical for dynein arm targeting and function within motile cilia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 56 (LRRC56).